|
STK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.11699996106086E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.75460012974816E-10 |
| Normal-vs-Stage2 |
5.804900E-03 |
| Normal-vs-Stage3 |
4.501600E-02 |
| Normal-vs-Stage4 |
3.141000E-01 |
| Stage1-vs-Stage2 |
2.128200E-01 |
| Stage1-vs-Stage3 |
2.855500E-02 |
| Stage1-vs-Stage4 |
1.140830E-01 |
| Stage2-vs-Stage3 |
5.325800E-01 |
| Stage2-vs-Stage4 |
5.310400E-01 |
| Stage3-vs-Stage4 |
8.835600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.54670004265989E-09 |
| Normal-vs-AfricanAmerican |
1.7684799999973E-05 |
| Normal-vs-Asian |
6.409400E-01 |
| Caucasian-vs-AfricanAmerican |
5.677800E-01 |
| Caucasian-vs-Asian |
3.301600E-01 |
| AfricanAmerican-vs-Asian |
6.163200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.60700033677597E-10 |
| Normal-vs-Female |
2.382000E-03 |
| Male-vs-Female |
4.942400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.963800E-04 |
| Normal-vs-Extreme_Weight |
3.30340000020968E-07 |
| Normal-vs-Obese |
3.209500E-04 |
| Normal-vs-Extreme_Obese |
1.260280E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.968800E-01 |
| Normal_Weight-vs-Obese |
5.312600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.297600E-01 |
| Extreme_Weight-vs-Obese |
1.330190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.051800E-01 |
| Obese-vs-Extreme_Obese |
2.532200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.588200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.20060000011691E-07 |
| Normal-vs-Age(61-80Yrs) |
3.09019998478988E-09 |
| Normal-vs-Age(81-100Yrs) |
1.80384999999283E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.792300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.770000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.863700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.438750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.740800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.365000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.6034954454276E-11 |
| Normal-VS-Type2 PRCC |
1.420530E-03 |
| Normal-VS-KIRP CIMP |
8.783400E-01 |
| Normal-VS-Unclassified PRCC |
2.29229999999525E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.600200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.122000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.307000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.191150E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.987150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.724600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.80390000054298E-07 |
| Normal-vs-N1 |
5.559200E-01 |
| Normal-vs-N2 |
8.432200E-01 |
| N0-vs-N1 |
4.322700E-03 |
| N0-vs-N2 |
4.542400E-02 |
| N1-vs-N2 |
6.451800E-01 |
|
|
